Which medications in the drug class Antineoplastic, mTOr Kinase Inhibitor are used in the treatment of Insulinoma?

Updated: May 31, 2020
  • Author: Zonera Ashraf Ali, MBBS; Chief Editor: Neetu Radhakrishnan, MD  more...
  • Print

Antineoplastic, mTOr Kinase Inhibitor

Mammalian target of rapamycin (mTOr), a serine-threonine kinase is dysregulated in several human cancers. Inhibitors of mTOR reduces cell proliferation, angiogenesis, and glucose uptake.

Everolimus (Afinitor)

Everolimus is indicated for progressive neuroendocrine tumors (PNET) located in the pancreas that are not surgically resectable or are metastatic. It is also indicated for well-differentiated, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!